SNCA and Parkinson disease: Reprogramming fibroblasts from PD patients with SNCA triplication using conventional OSKM factors (Fig. 1) and differentiation by dual inhibition118 or differentiation by removal of growth factor119 resulted in DA neurons that exhibited approximately twice the levels of α-synuclein compared to unaffected first-degree relatives67,118,119.